Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00945893 · ClinicalTrials.gov registry record · Phase 4
A Study to Evaluate the Safety of H1N1 Monovalent Vaccine (MEDI3414) in Healthy Adults
A Phase 4 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT00945893 is a Phase 4 study that has completed, run by MedImmune. The registered enrollment target is 300 participants.
The verdict
NCT00945893, a Phase 4 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study was to determine the safety and descriptive immunogenicity of the H1N1 influenza vaccine in healthy adults.
Interventions
- OTHER Placebo
- BIOLOGICAL MEDI3414 [Influenza A/H1N1 live attenuated, intranasal]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00945893
The ClinicalTrials.gov registry entry for NCT00945893 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00945893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00945893 about?
NCT00945893 is a clinical study titled "A Study to Evaluate the Safety of H1N1 Monovalent Vaccine (MEDI3414) in Healthy Adults". The purpose of this study was to determine the safety and descriptive immunogenicity of the H1N1 influenza vaccine in healthy adults.
What is the current status of trial NCT00945893?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2009-08. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00945893?
The interventions under investigation include: Placebo (OTHER), MEDI3414 [Influenza A/H1N1 live attenuated, intranasal] (BIOLOGICAL).
Who is sponsoring clinical trial NCT00945893?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.